<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND and PURPOSE: Animal research and clinical studies in head trauma patients suggest that moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> may improve outcome by attenuating the deleterious metabolic processes in neuronal injury </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical studies on moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> in the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> patients are still lacking </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> was induced in 25 patients with severe <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in the middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) territory for therapy of postischemic <z:hpo ids='HP_0002181'>brain edema</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0002045'>Hypothermia</z:hpo> was induced within 14+/-7 hours after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> and achieved by external cooling with cooling blankets, cold infusions, and cold washing </plain></SENT>
<SENT sid="4" pm="."><plain>Patients were kept at 33 degreesC body-core temperature for 48 to 72 hours, and intracranial pressure (ICP), cerebral perfusion pressure, and brain temperature were monitored continuously </plain></SENT>
<SENT sid="5" pm="."><plain>Outcome at 4 weeks and 3 months after the <z:hpo ids='HP_0001297'>stroke</z:hpo> was analyzed with the Scandinavian <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale (SSS) and Barthel index </plain></SENT>
<SENT sid="6" pm="."><plain>The side effects of induced moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> were analyzed </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Fourteen patients survived the hemispheric <z:hpo ids='HP_0001297'>stroke</z:hpo> (56%) </plain></SENT>
<SENT sid="8" pm="."><plain>Neurological outcome according to the SSS score was 29 (range, 25 to 37) 4 weeks after <z:hpo ids='HP_0001297'>stroke</z:hpo> and 38 (range 28 to 48) 3 months after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>During <z:hpo ids='HP_0002045'>hypothermia</z:hpo>, elevated ICP values could be significantly reduced </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0019270" disease_type="Disease or Syndrome" abbrv="">Herniation</z:e> caused by a secondary rise in ICP after rewarming was the cause of <z:hpo ids='HP_0011420'>death</z:hpo> in <z:hpo ids='HP_0000001'>all</z:hpo> remaining patients </plain></SENT>
<SENT sid="11" pm="."><plain>The most frequent complication of moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> was <z:hpo ids='HP_0002090'>pneumonia</z:hpo> in 10 of the 25 patients (40%) </plain></SENT>
<SENT sid="12" pm="."><plain>Other severe side effects of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> could not be detected </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> in the treatment of severe <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> is not associated with severe side effects </plain></SENT>
<SENT sid="14" pm="."><plain>Moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> can help to control critically elevated ICP values in severe space-occupying <z:hpo ids='HP_0000969'>edema</z:hpo> after <z:chebi fb="70" ids="34342">MCA</z:chebi> <z:hpo ids='HP_0001297'>stroke</z:hpo> and may improve clinical outcome in these patients </plain></SENT>
</text></document>